{"database": "openregs", "table": "dockets", "rows": [["FDA-2025-P-6350", "FDA", "Requests that the FDA initiate notice-and-comment rulemaking to amend 21 CFR \u00a7 1271.90 to extend the existing regulatory exception for surplus cryopreserved embryos to surplus cryopreserved oocytes originally recovered for a woman\u2019s own reproductive use", "Nonrulemaking", "2026-05-14T14:12:30Z", "0b000064b908aac4"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2025-P-6350"], "units": {}, "query_ms": 0.4060110077261925, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}